Metformin-induced lactic acidosis;Acidosis láctica por metformina

Endocrinologia y Nutricion

Volumn 54, Issue 6, 2007, Pages 325-327

  De La Maza Pereg, Laura ^a   Hierro, Víctor Manuel García ^a   Baños, Pilar Álvarez ^a   Barrio, Javier Pi ^a   López, Luis Castillo ^a   Pérez, Enrique Ruiz ^a  

^a HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Kidney failure; Lactic acidosis; Metformin

Indexed keywords

CAPTOPRIL; CREATININE; INDAPAMIDE; INSULIN; LACTIC ACID; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; UREA;

ABDOMINAL PAIN; AGED; ARTICLE; CASE REPORT; DIARRHEA; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; KIDNEY FAILURE; LABORATORY TEST; LACTIC ACIDOSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; RISK FACTOR; VOMITING;

EID: 34547736078     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/S1575-0922(07)71457-2     Document Type: Article

References (16)

1. Gan SC, Barr J, Arrieff Al, Pearl RG. Biguanide associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992;152:2333-6.
2. Stang M, Wysowski DK, Butler Jones D. Incidende of lactic acidosis in metformin users. Diabetes Care. 1999;22:925.
3. Sulkin TV, Bosman D, Krentz AJ. Contraindications to metformin therapy in patients with NIDDM. Diabetes Care. 1997;20:925.
4. Bailey CJ. Biguanides and NIDDM. Diabetes Care. 1992;15:755.
5. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334:574.
6. Stumvoll M, Nurijhan N, Periello G. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:550.
7. Schafer G. Biguanides: A review of history, pharmacodynamics and therapy. Diab Metab. 1983;9:148.
8. Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and non fatal lactic acidosis with metformin use in type 2 diabetes mellitus. Systematic review and meta-analysis. Arch Intern Med. 2003;163:2594-602.
9. Sirtori CR, Pasik C. Re-evaluation of a biguanide: mechanism of action and tolerability. Pharmacol Res. 1994;30:187.
10. Horlen C, Malone R, Dennis B, Carey T. Frecuency of innapropiate metformin prescriptions. JAMA. 2002;287:2504.
11. Calabrese AT, Caley KC, Da Pos SV. Evaluation of prescribing practices; risk of lactic acidosis with metformin therapy. Arch Intern Med. 2002;162:434.
12. Eurich DT, Majumdar SR, McAlister FA, Tsuyuki RT, Johnson JA. Improved clinical outcomes associated with metformin in patients with diabetes and heart failure. Diabetes Care. 2005;28:2345-51.
13. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformina and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005;111:583-90.
14. Lalau JD, Race JM. Metformin and lactic acidosis in diabetic humans. Diabetes Obes Metab. 2000;2:131-7.
15. Lalau JD, Race JM. Lactic acidosis in metformin therapy: searching for a link with metformin reports of metformin-associatted lactic acidosis. Diabetes Obes Metab. 2001;3:195-201.
16. Heaney D, Majhid A, Junor B. Bicarbonate haemodialysis as a treatment of metformin overdose. Nephrol Dial Transplant. 1997;12:1046-7.